Sara Selig

8PUBLICATIONS
30CO-AUTHORS
Tissue engineeringEpigenetics (incl. genome methylation and epigenomics)Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 08, 2025
Missense substitutions in the BTB domain of ZBTB24 can lead to protein instability and cause ICF2 syndrome.

Or Givol, Ido S Han, Francesco Cecere

|Dec 23, 2023
ICF1-Syndrome-Associated DNMT3B Mutations Prevent De Novo Methylation at a Subset of Imprinted Loci during iPSC Reprogramming.

Ankit Verma, Varsha Poondi Krishnan, Francesco Cecere

|Feb 24, 2023
The aberrant epigenome of DNMT3B-mutated ICF1 patient iPSCs is amenable to correction, with the exception of a subset of regions with H3K4me3- and/or CTCF-based epigenetic memory.

Varsha Poondi Krishnan, Barbara Morone, Shir Toubiana

|Feb 15, 2022
Comparative Analysis of the APOL1 Variants in the Genetic Landscape of Renal Carcinoma Cells.

Maty Tzukerman, Yeela Shamai, Ifat Abramovich

|May 13, 2021
RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function.

Nadra Samra, Shir Toubiana, Hilde Yttervik

|Apr 03, 2021
Epigenetic Characteristics of Human Subtelomeres Vary in Cells Utilizing the Alternative Lengthening of Telomeres (ALT) Pathway.

Shir Toubiana, Aya Tzur-Gilat, Sara Selig

Pageof 2

Frequent Collaborators

3 joint publications

Maria R Matarazzo

3 joint publications

Shir Toubiana

2 joint publications

Claudia Angelini

2 joint publications

Varsha Poondi Krishnan